Skip to main content
Premium Trial:

Request an Annual Quote

Trangenomic s Q4 Sales Decline 21 Percent As Net Loss Nearly Doubles

NEW YORK, March 17 (GenomeWeb News) - Transgenomic yesterday reported a 21.3-percent decrease in net sales and a greater net loss for the fourth quarter.


Sales for the three months ended Dec. 31, 2005, declined to $5.3 million from $6.8 million in the year-ago period.


The company's net loss for the fourth quarter almost doubled to $11.2 million, compared with $6.9 million in Q4 2005.


Transgenomic did not break out its R&D expenses.


As of Dec. 31, Transgenomic had $6.7 million in cash and cash equivalents.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.